BioSpace News Archive

Jaguar Health, Inc. announced that Ladenburg Thalmann is hosting a live virtual “Duologue Series” discussion at 1:00 p.m. EDT on June 22, 2023 with Lisa Conte, Jaguar’s founder, president and CEO.

Palisade Bio announced that J.D. Finley, Chief Executive Officer of Palisade Bio will present at the Healthcare Virtual Conference Part II, presented by Maxim Group LLC and hosted by M-Vest on Thursday, June 22, 2023 at 11:30 AM ET.

Nanotein Technologies, a trailblazing leader in innovative cell therapy reagents, recently launched their latest addition to the NanoSpark™ product line: NanoSpark™ GROW-NK Soluble Activator.

Labcorp is pleased to share that its executive vice president and chief marketing officer, Amy Summy, has been awarded the inaugural Forrester Customer Obsession Leadership Award, recognizing senior executives who put customers at the center of everything they do to accelerate business growth, retain customers and enable greater employee engagement.

CancerVAX, Inc., developer of a breakthrough universal cancer vaccine that will use the body’s immune system to fight cancer, announced that it recently launched a funding round of up to $10 million.

Ventyx Biosciences, Inc. announced that the first subject has been dosed in a Phase 1 trial of VTX3232, a novel central nervous system -penetrant NLRP3 inhibitor.

Nurix Therapeutics, Inc. announced the presentation of clinical and preclinical data from its targeted protein degradation programs, NX-5948 and NX-2127, which are being evaluated in ongoing Phase 1 clinical trials in patients with relapsed/refractory B cell malignancies.

Kura Oncology, Inc., a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, announced the pricing of an underwritten public offering of common stock and pre-funded warrants.

Actinium Pharmaceuticals, Inc., a leader in the development of targeted radiotherapies, announced that the Company will participate in a fireside chat at the TD Cowen Radiopharmaceutical Innovation Summit on Tuesday, June 20, 2023 at 1:30 PM EST.

Seismic Therapeutic, Inc. announced nine poster presentations supporting the company’s emerging pipeline of novel biologics derived from its proprietary IMPACT platform to treat autoimmune diseases at the 23rd Annual Meeting of the Federation of Clinical Immunology Societies taking place on June 20-23 in Boston, MA.